Fracture performance of GFRP-RC beams with working cracks in alkaline environment for eight years

2021 ◽  
Vol 299 ◽  
pp. 123757
Author(s):  
Weiwei Wu ◽  
Xiongjun He ◽  
Chao Wu ◽  
Jia He ◽  
Wenrui Yang
2011 ◽  
Vol 201-203 ◽  
pp. 2931-2934
Author(s):  
Yan Feng Feng ◽  
Tian Hong Yang ◽  
Hua Wei ◽  
You Fa Gu ◽  
Hai Jun Wang

With technology of FRP reinforcement concrete beams is applied in domain of the civil engineering, it attracts more and more scholars to study it. The paper studied of the flexural fracture performance of FRP reinforced RC beams, bringing forward how to calculate the flexural failure of FRP reinforced concrete beam, namely: bearing capacity formula about broken FRP and crushed concrete on compression zone, through comparison between calculated values and tests values, it is discovered that the numerical analysis and test result is fitting approximately, it is validated that the formula can well analyze flexural of FRP reinforced RC beams.


2016 ◽  
Vol 20 (6) ◽  
pp. 04016040 ◽  
Author(s):  
Wen-rui Yang ◽  
Xiong-jun He ◽  
Li Dai ◽  
Xia Zhao ◽  
Feng Shen

2018 ◽  
Vol 1 (1) ◽  
pp. 30-42
Author(s):  
Muataz Ali ◽  
◽  
Yaseen Saleh ◽  
Luna Al Hasani ◽  
Ammar Khazaal ◽  
...  
Keyword(s):  
Rc Beams ◽  

Author(s):  
Neeraj Agrawal ◽  
M.J. Chandrasekar ◽  
U.V. Sara ◽  
Rohini A.

A macromolecular prodrug of didanosine (ddI) for oral administration was synthesized and evaluated for in-vitro drug release profile. Didanosine was first coupled to 2-hydroxy ethyl methacrylate (HEMA) through a succinic spacer to form HEMA-Suc-ddI monomeric conjugate which was subsequently polymerized to yield Poly(HEMA-Suc-ddI) conjugate. The structures of the synthesized compounds were characterized by FT-IR, Mass and 1H-NMR spectroscopy. The prodrug was subjected for in-vitro drug release studies in buffers of pH 1.2 and 7.4 mimicking the upper and lower GIT. The results showed that the drug release from the polymeric backbone takes place in a sustained manner over a period of 24 h and the amount of drug released was comparatively higher at pH 7.4 indicating that the drug release takes place predominantly at the alkaline environment of the lower GIT rather than at the acidic environment of the upper GIT. This pH dependent sustained drug release behavior of the prodrug may be capable of reducing the dose limiting toxicities by maintaining the plasma drug level within the therapeutic range and increasing t1/2 of ddI. Moreover, the bioavailability of the drug should be improved as the prodrug releases ddI predominantly in the alkaline environment which will reduce the degradation of ddI in the stomach acid.


2018 ◽  
Vol 8 (1) ◽  
pp. 1
Author(s):  
RIHAN MAAZE MOHAMMED ◽  
SHOEB MUDASSIR ◽  
◽  
Keyword(s):  

2016 ◽  
Vol 106 (6) ◽  
pp. 708-715
Author(s):  
Chenwei HOU ◽  
Takuro NAKAMURA ◽  
Takayuki IWANAGA ◽  
Junichiro NIWA
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document